The bone profile B test is a specialized diagnostic blood panel used to evaluate skeletal metabolism, mineral balance, and bone turnover rates. This expanded assessment typically measures serum calcium, phosphate, alkaline phosphatase (ALP), albumin, and adjusted calcium levels, alongside extended metabolic markers.
By analyzing these biochemical components together, healthcare providers can assess how efficiently bones form and break down. The test is essential for identifying and monitoring systemic disorders such as hyperparathyroidism, Paget's disease, vitamin deficiencies, and renal-related bone mineral complications, ensuring targeted and effective clinical management.

The Bad Obstetric History (BOH) panel test is a comprehensive diagnostic blood evaluation recommended for women who have experienced recurrent pregnancy losses, such as consecutive spontaneous miscarriages, stillbirths, or early neonatal deaths.
This panel primarily investigates underlying medical triggers by screening for chronic infections—such as TORCH agents—autoimmune and blood-clotting disorders like antiphospholipid syndrome, and hormonal imbalances including thyroid dysfunction. By precisely identifying these root causes, healthcare providers can design targeted treatment plans to support safer, healthier outcomes in future pregnancies.

The Blood Toxic Element Profile Test is a comprehensive diagnostic panel designed to measure the levels of hazardous heavy metals and toxic substances circulating in the bloodstream. This specialized screening evaluates exposure to harmful elements such as lead, mercury, arsenic, cadmium, and aluminum, which can accumulate from environmental pollution, occupational hazards, or dietary sources. Elevated concentrations of these heavy metals can cause severe systemic damage affecting neurological, renal, and cardiovascular functions. By accurately quantifying these toxic loads, healthcare providers can identify acute or chronic poisoning, monitor detoxification treatments, and implement targeted interventions.

The bladder mass medium biopsy (1-3 cm test) is a targeted pathological procedure used to evaluate tissue growths measuring between one and three centimeters located within the urinary bladder.
During cystoscopy, a specialist collects a medium-sized tissue sample from the suspicious lesion. This sample undergoes detailed microscopic examination by a pathologist to determine whether the mass is benign or malignant, and to grade its cellular structure.
Accurately diagnosing a bladder mass of this scale is crucial for staging urothelial carcinoma or other conditions, enabling physicians to formulate precise treatment strategies and surgical interventions.

A bicarbonate test is a routine blood check that measures the amount of carbon dioxide in your body, mostly in the form of bicarbonate. This test helps doctors evaluate your electrolyte balance and acid-base status. Bicarbonate acts as an essential buffer, keeping your blood pH stable so your vital organs can function correctly.
Abnormal levels can signal underlying health issues like kidney disease, breathing disorders, or severe dehydration. Doctors frequently order this test as part of a basic metabolic panel to monitor your overall metabolic health and internal chemical balance.

A Beta Thalassemia screening is a simple blood test used to see if you carry the gene for this inherited blood disorder. It’s important to know if you are a carrier, especially when planning a family.
The screening usually starts with a complete blood count (CBC) to look at the size and shape of your red blood cells. If the results are unusual, a more specific test called Hemoglobin Electrophoresis is performed.
This specialized test separates and measures different types of hemoglobin, the protein in red blood cells that carries oxygen. The resulting graph, called an electropherogram, shows distinct peaks for each type. A carrier will show specific, identifiable patterns and levels of Hemoglobin A2 or Hemoglobin F that are different from a person who does not carry the trait.
This graph is the key tool doctors use to provide an accurate diagnosis.

A Beta Thalassemia screening test is a simple blood check used to see if a person carries the gene for this inherited blood disorder. Doctors usually start with a Complete Blood Count (CBC) to check the size and shape of your red blood cells. If those results look unusual, a specialized test called Hemoglobin Electrophoresis is done to look closer at your protein types.
Getting screened is important because people can carry the gene without showing any symptoms. Knowing your status helps you make informed family planning decisions and keeps you aware of your health.

The Beta-hCG test measures the level of human chorionic gonadotropin, often called the "pregnancy hormone," in your blood or urine. This hormone is naturally produced by cells that eventually form the placenta shortly after a fertilized egg implants in the uterus. Doctors most commonly use this test to confirm whether you are pregnant. Quantitative blood tests can also measure the exact amount of hCG to help monitor early pregnancy development, check for potential complications like ectopic pregnancies, or track recovery after a miscarriage. It is a quick and reliable way to get vital health insights.

The beta-2 microglobulin (B2M) test measures the amount of a small protein found on the surface of most cells in your body. Small amounts naturally shed into your blood and urine, but high levels can mean certain cells are turning over too quickly or your immune system is working overtime. Doctors usually order this test to help diagnose, monitor, or check the severity of blood cancers like multiple myeloma, lymphoma, and certain leukemias. It can also help evaluate kidney damage or inflammatory conditions, giving your healthcare team important insights into your overall health and treatment progress.

The Beta-2 Glycoprotein 1 IgG test is an automated immunoassay used to detect IgG-class autoantibodies directed against beta-2 glycoprotein 1, a key plasma protein. Elevated levels of these autoantibodies are strongly associated with antiphospholipid syndrome (APS), a systemic autoimmune condition characterized by recurrent arterial or venous thrombosis and adverse pregnancy outcomes. Along with lupus anticoagulant and anticardiolipin antibodies, this test serves as a major diagnostic criterion for APS. Identifying these antibodies helps clinicians stratify thrombotic risk, evaluate unexplained blood clotting events, and guide long-term management and therapeutic anticoagulation strategies for affected patients.

A **Basic Arthritis Profile for Male** is a targeted blood panel designed to evaluate systemic inflammation and identify markers associated with various arthritic conditions. This profile typically includes tests such as Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) to detect generalized inflammatory responses, along with Rheumatoid Factor (RF) and sometimes Anti-CCP to screen for autoimmune joint diseases. Additionally, Uric Acid levels are frequently measured to assess for gout, a condition notably prevalent in men. By analyzing these specific biomarkers, healthcare providers can differentiate between inflammatory and non-inflammatory joint pain, facilitating an accurate diagnosis and timely intervention to preserve long-term joint health.

Back Swelling – Large Biopsy (3–6 cm)

A Back Swelling – Large Biopsy (3–6 cm) is a procedure in which a tissue sample is taken from a larger lump or swelling on the back for laboratory examination. It helps identify the exact cause, such as a benign growth, infection, inflammation, cyst, or cancer. The biopsy is usually performed under local anesthesia, making it a safe and minimally uncomfortable procedure. Accurate diagnosis allows doctors to plan the most appropriate treatment and avoid unnecessary surgery. If you notice a persistent, enlarging, or painful back swelling, consult your healthcare provider promptly for proper evaluation and timely management.